Min‐Liang Kuo

15.8k total citations · 1 hit paper
191 papers, 13.1k citations indexed

About

Min‐Liang Kuo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Min‐Liang Kuo has authored 191 papers receiving a total of 13.1k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Molecular Biology, 61 papers in Oncology and 37 papers in Cancer Research. Recurrent topics in Min‐Liang Kuo's work include Angiogenesis and VEGF in Cancer (26 papers), Connective Tissue Growth Factor Research (20 papers) and Cytokine Signaling Pathways and Interactions (20 papers). Min‐Liang Kuo is often cited by papers focused on Angiogenesis and VEGF in Cancer (26 papers), Connective Tissue Growth Factor Research (20 papers) and Cytokine Signaling Pathways and Interactions (20 papers). Min‐Liang Kuo collaborates with scholars based in Taiwan, United States and India. Min‐Liang Kuo's co-authors include Ming‐Tsan Lin, Lin‐Hung Wei, Pan‐Chyr Yang, Yung‐Ming Jeng, Jen‐Kun Lin, Shuang‐En Chuang, Tze‐Sing Huang, Chia‐Yu Chu, Jen-Liang Su and Shiou‐Hwa Jee and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Min‐Liang Kuo

189 papers receiving 12.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pretreatment Epidermal Growth Factor Receptor ( EGFR ) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer

2012 429 citations Kang‐Yi Su, Hsuan‐Yu Chen et al. Journal of Clinical Oncology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Min‐Liang Kuo	7.6k	3.8k	2.8k	2.0k	1.2k	191	13.1k
Zhiwei Wang	8.8k 1.2×	4.4k 1.1×	3.4k 1.2×	1.2k 0.6×	1.1k 0.9×	250	13.6k
Mayumi Ono	7.4k 1.0×	4.0k 1.0×	2.2k 0.8×	1.7k 0.9×	1.9k 1.6×	214	12.1k
Chris Albanese	10.0k 1.3×	5.9k 1.5×	2.9k 1.1×	1.9k 1.0×	1.2k 1.0×	135	15.5k
Graeme I. Murray	5.5k 0.7×	4.4k 1.1×	3.6k 1.3×	965 0.5×	1.2k 1.0×	197	12.0k
Zhi Yao	6.3k 0.8×	3.0k 0.8×	2.6k 0.9×	1.8k 0.9×	1.0k 0.9×	258	10.5k
Shahab Uddin	7.9k 1.0×	5.0k 1.3×	2.8k 1.0×	3.5k 1.8×	845 0.7×	385	15.1k
Tao Liu	10.1k 1.3×	2.3k 0.6×	5.0k 1.8×	1.8k 0.9×	1.1k 0.9×	502	16.2k
Zhi‐Nan Chen	7.2k 0.9×	2.2k 0.6×	2.8k 1.0×	2.7k 1.4×	1.6k 1.4×	349	11.2k
Hong Zhao	4.7k 0.6×	3.9k 1.0×	1.7k 0.6×	2.9k 1.5×	1.4k 1.2×	273	12.5k
Linda S. Steelman	7.5k 1.0×	3.3k 0.9×	1.9k 0.7×	990 0.5×	1.1k 0.9×	112	11.2k

Countries citing papers authored by Min‐Liang Kuo

Since Specialization

Citations

This map shows the geographic impact of Min‐Liang Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min‐Liang Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min‐Liang Kuo more than expected).

Fields of papers citing papers by Min‐Liang Kuo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min‐Liang Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min‐Liang Kuo. The network helps show where Min‐Liang Kuo may publish in the future.

Co-authorship network of co-authors of Min‐Liang Kuo

This figure shows the co-authorship network connecting the top 25 collaborators of Min‐Liang Kuo. A scholar is included among the top collaborators of Min‐Liang Kuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min‐Liang Kuo. Min‐Liang Kuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Chia‐Wen, Kuo‐Tai Hua, Kaichun Li, et al.. (2017). Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate–Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma. Molecular Cancer Therapeutics. 16(7). 1421–1434. 48 indexed citations

Chien, Ming‐Hsien, Wei-Jiunn Lee, Tsu‐Yao Cheng, et al.. (2015). Keap1–Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P Protein. Clinical Cancer Research. 21(20). 4719–4732. 41 indexed citations

Chen, Chia‐Hung, Min‐Liang Kuo, Wei‐Chuan Liao, et al.. (2015). CCM-AMI, a Polyethylene Glycol Micelle with Amifostine, as an Acute Radiation Syndrome Protectant in C57BL/6 Mice. Health Physics. 109(3). 242–248. 11 indexed citations

Chang, Cheng‐Chi, Wen‐Hao Hsu, Mark Yen‐Ping Kuo, et al.. (2013). Connective Tissue Growth Factor Activates Pluripotency Genes and Mesenchymal–Epithelial Transition in Head and Neck Cancer Cells. Cancer Research. 73(13). 4147–4157. 75 indexed citations

Su, Kang‐Yi, Hsuan‐Yu Chen, Ker-Chau Li, et al.. (2012). Pretreatment Epidermal Growth Factor Receptor ( EGFR ) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 30(4). 433–440. 429 indexed citations breakdown →

Lin, Been‐Ren, Cheng‐Chi Chang, Robert J. Chen, et al.. (2011). Connective Tissue Growth Factor Acts as a Therapeutic Agent and Predictor for Peritoneal Carcinomatosis of Colorectal Cancer. Clinical Cancer Research. 17(10). 3077–3088. 27 indexed citations

Chen, Pai‐Sheng, Jen-Liang Su, Woan‐Yuh Tarn, et al.. (2011). miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans. Journal of Clinical Investigation. 121(9). 3442–3455. 125 indexed citations

Pan, Szu‐Hua, Hsuan-Yu Chen, Yih‐Leong Chang, et al.. (2011). The ability of LCRMP-1 to promote cancer invasion by enhancing filopodia formation is antagonized by CRMP-1. Journal of Clinical Investigation. 121(8). 3189–3205. 63 indexed citations

Chen, Min-Wei, Kuo‐Tai Hua, Lin‐Hung Wei, et al.. (2010). H3K9 Histone Methyltransferase G9a Promotes Lung Cancer Invasion and Metastasis by Silencing the Cell Adhesion Molecule Ep-CAM. Cancer Research. 70(20). 7830–7840. 297 indexed citations

10.

Lo, Chi‐Wen, Min‐Wei Chen, Michael Hsiao, et al.. (2010). IL-6 Trans-Signaling in Formation and Progression of Malignant Ascites in Ovarian Cancer. Cancer Research. 71(2). 424–434. 152 indexed citations

11.

Chen, Pai‐Sheng, Gunnar Johansson, Chia‐Yu Chu, et al.. (2010). MicroRNA-519c Suppresses Hypoxia-Inducible Factor-1α Expression and Tumor Angiogenesis. Cancer Research. 70(7). 2675–2685. 168 indexed citations

12.

Yeh, Tien-Shun, et al.. (2009). The Activated Notch1 Signal Pathway Is Associated with Gastric Cancer Progression through Cyclooxygenase-2. Cancer Research. 69(12). 5039–5048. 145 indexed citations

13.

Wang, Ming-Yang, Pai‐Sheng Chen, Ekambaranellore Prakash, et al.. (2009). Connective Tissue Growth Factor Confers Drug Resistance in Breast Cancer through Concomitant Up-regulation of Bcl-xL and cIAP1. Cancer Research. 69(8). 3482–3491. 81 indexed citations

14.

Chen, You‐Tzung, Kenryo Furushima, Amy T. Ku, et al.. (2009). PiggyBac Transposon-Mediated, Reversible Gene Transfer in Human Embryonic Stem Cells. Stem Cells and Development. 19(6). 763–771. 30 indexed citations

15.

Shen, Che-Hung, Hsin‐Yi Chen, Cheng‐Chi Chang, et al.. (2008). Breast Tumor Kinase Phosphorylates p190RhoGAP to Regulate Rho and Ras and Promote Breast Carcinoma Growth, Migration, and Invasion. Cancer Research. 68(19). 7779–7787. 72 indexed citations

16.

Lu, Yen‐Shen, et al.. (2006). Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-κB activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa. Journal of Endocrinology. 188(2). 311–319. 19 indexed citations

17.

Su, Jen-Liang, Jin‐Yuan Shih, Ming‐Shyen Yen, et al.. (2004). Cyclooxygenase-2 Induces EP1- and HER-2/Neu-Dependent Vascular Endothelial Growth Factor-C Up-Regulation. Cancer Research. 64(2). 554–564. 165 indexed citations

18.

Tzeng, Huei‐Ping, et al.. (2003). β-Lapachone Reduces Endotoxin-induced Macrophage Activation and Lung Edema and Mortality. American Journal of Respiratory and Critical Care Medicine. 168(1). 85–91. 38 indexed citations

19.

Jee, Shiou‐Hwa, Hsien‐Ching Chiu, Tsen‐Fang Tsai, et al.. (2002). The Phosphotidyl Inositol 3-Kinase/Akt Signal Pathway Is Involved in Interleukin-6-mediated Mcl-1 Upregulation and Anti-apoptosis Activity in Basal Cell Carcinoma Cells. Journal of Investigative Dermatology. 119(5). 1121–1127. 39 indexed citations

20.

Yang, James Chih‐Hsin, et al.. (2000). BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells. Biochemical Pharmacology. 60(6). 831–837. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact